Velano Vascular develops vascular access technologies for hospital inpatients and is led by CEO Eric M. Stone. Its FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high-quality blood draws. The device is positioned to deliver painless, compassionate care for patients, improve safety for caregivers, and offer a more financially responsible alternative for health systems. The company provides a family of products that enable blood draws from indwelling peripheral IV catheters. Velano intends to use newly raised funds to accelerate commercialization and to launch additional novel inpatient medical device solutions. As of the latest tranche, the company has raised more than $50 million in total funding. Velano Vascular develops human-centered vascular access technologies and is based in San Francisco. The company is advancing the PIVO™ needle-free, single-use disposable device that enables high-quality blood samples via indwelling peripheral IV lines. PIVO is intended to reduce hospitals' reliance on repeat needle sticks and central line access, improving the blood draw experience for patients and practitioners. Velano raised $17M in financing to scale and commercialize its family of vascular access technologies. Backers on the financing included a publicly traded healthcare company and a global supplier alongside existing investors. The company is led by CEO Eric M. Stone. Velano Vascular develops a single-use, disposable device intended to standardize blood draws through patients' existing peripheral IV (PIV) catheters, reducing reliance on repeat needle sticks and central line blood draws. The company aims to improve the care experience for hospitalized patients and their practitioners and is advancing its technology for both adult and pediatric populations. It is working to better understand and evaluate the technology in pediatric patients and will initiate pilot programs this year exploring the device in medical centers and departments that serve adult and pediatric patients. Velano raised an additional $3.5M to support development and commercialization of its inpatient blood-draw technology and had completed a $5M Series A in January 2015. Leadership includes co-founder and CEO Eric M. Stone and newly added VP of Manufacturing and Operations Quinton J. Farrar. The company is based in San Francisco and also maintains an office in Philadelphia. Velano Vascular develops patented medical technology intended to reduce needle sticks during the inpatient blood-draw procedure and to enhance safety for providers. The company’s core product is a vascular access device aimed at improving blood-draw safety and workflow in hospitals. Velano was founded in 2012 and is led by president Pitou Devgon, MD, and CEO Eric M. Stone. It is based in Philadelphia, PA and San Francisco, CA. The company plans to use recently raised capital to move into clinical evaluation and into early commercialization with select hospital partners. The articles do not report revenue or user metrics.

Total raised

$51M

Funding rounds

4

Latest round

Equity

Latest activity

Dec 2019